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ABSTRACT
Understanding the heterogeneous nature of cancer tissue is a very important problem in
cancer research. It can give insights into the cause of disease, its progression and explain
induced drug resistance. There are two models that are used to explain heterogeneity,
Cancer Stem Cells and Clonal Evolution. This thesis aims to address this challenge by
developing an algorithm to determine the ratio of different components of a heterogeneous
cancer tissue. This algorithm is robust and does not depend on the heterogeneity model.
The proposed algorithm uses response vector, which is a vector of observable response of
cell lines. A database of the response of individual cell lines is developed by collecting
cell-by-cell response measurements. A heterogeneous cancer tissue is modeled as being
a mixture of these cell lines. Avoiding the high cost cell-by-cell analysis, the collective
response of the heterogeneous cancer tissue is observed. The algorithm uses Bayesian
inference to estimate the probability distribution of the number of cells of individual cell
lines based on the response of individual cell lines and the observed collective response.
The results of the algorithm are validated using synthetic data and real-world data collected
from cell lines, which are mixed in a ratio known a priori.
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1. INTRODUCTION AND CURRENT STATE OF KNOWLEDGE
1.1 Introduction
Cancer is a disease caused by loss of cell-cycle control. Loss of cell-cycle control
results in unregulated cell proliferation and/or reduced cell apoptosis. It may occur due to
mutations in proto-oncogenes, which are responsible for the regulation of cell-growth and
differentiation, or in tumor suppressor genes that inhibit cell division and survival. Cancer
progression can be modeled using two models - Cancer Stem Cells and Clonal Evolution.
Both these models have different explanations to account for the heterogeneity observed
in cancer tissues.
Diving into cancer tissue heterogeneity is a very crucial factor in cancer treatment.
Tracking the composition of cancer tissue can give an insight into the cause and progres-
sion of a particular cancer. Heterogeneity has posed a serious challenge in the design of
effective therapy. The only kinds of cancers for which a high rate of therapeutic success
has been achieved, namely chronic myelogenous leukemia (CML) and acute promyelo-
cytic leukemia (APML), are normally not heterogeneous in nature. Moreover, as a partic-
ular dominant subpopulation is targeted for killing via drugs, other subpopulations usually
emerge requiring a different therapy. Clearly, this can contribute to the mechanism of
acquired drug resistance, which is quite commonly encountered in cancer treatment [1].
Thus, the problem of identifying dominant subpopulations in a cancer tissue is of utmost
importance for therapeutic purposes and the goal of the proposed research is to demon-
strate the viability of a possible solution to it, based on imaging the fluorescence.
1.2 Current State of Knowledge
There are two models used to explain heterogeneity in cancer tissues:
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1.2.1 Cancer Stem Cells
This model asserts that only a small fraction of all the cancer cells, called cancer stem
cells, are tumorigenic, that is , they are the ones responsible for the progression of cancer
when they reproduce. Their role can be compared to normal stem cells which are respon-
sible for sustaining the tissues and organs. By this theory, the cancer cells which are not
stem cells are harmful, but are incapable of sustaining the cancer over a period of time.
The proponents of this theory suggest therapies targeting stem cells. The Cancer Stem
Cell model explains cancer tissue heterogeneity as arising from differences in the stem
cells that give rise to the tumor. This variability in stem cells can arise due to epigenetic
changes.
1.2.2 Clonal Evolution
According to this model, cancer arises from mutations in a single cell. This mutation
is such that the mutated cell has a proliferative advantage over normal neighboring cells.
As this cell multiplies, new mutations accumulate at different cell division steps. Hence as
the cancer progresses, new varieties of cancer subpopulations become a part of the cancer
tissue making the tissue heterogeneous in nature [2].
A mathematical model to determine the heterogeneity of a cancer tissue is crucial
irrespective of the underlying model. It is important for the mathematical model to be
independent of the model used to explain heterogeneity as currently there is no consensus
on which is more accurate.
There have been various models suggested for determining heterogeneity in a cancer
tissue. A model based on gene expression was suggested in [3]. This model represents het-
erogeneity as a combination of deterministic Boolean Networks based on prior pathway
knowledge. It models heterogeneity by representing it as an inherent dirichlet distribu-
tion and uses hierarchical Bayesian model to arrive at the parameters of this distribution
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from the observed gene expression values. A major drawback of the approach is that the
prior knowledge in Boolean Networks is not accurate, which hampers the accuracy of
the results. In general, ensemble methods such as these are inaccurate when it comes to
determining the ratio of different cell lines. More accurate method for determining the
composition of heterogeneous cancer tissue was suggested in [4]. This model observes
responses of individual cells and infers which cell line they belong to. This method of in-
ferring the ratio of the components of the heterogeneous tissue is very accurate. However,
the high cost of the method makes it unaffordable. In this thesis, we propose an algorithm
which overcomes the accuracy constrains of ensemble methods as well as avoids the high
cost of a cell by cell analysis method.
3
2. ALGORITHM
2.1 The Idea
In this thesis we propose an algorithm that overcomes the challenges of ensemble
approaches, as well as avoids the high cost of cell-by-cell analysis. We utilize the cell-by-
cell analysis to gather the characteristics of the response of individual cell line classes. We
can make a database of the characteristics of different cell line classes. This is an expensive
process, but it needs to be done only once It is these characteristics that we utilize while
performing the analysis of heterogeneous tissue using ensemble methods. That is, once
the expensive cell-by-cell analysis is done for individual cell line classes, we can study
any number of heterogeneous tissues made up of members of those classes using low cost
ensemble methods.
2.2 Model
Let C = (C1, C2, . . . , Cn) be the different types of cells lines in the tissue. Let
pi = (pi1, pi2, . . . pin) be the ratio of the corresponding cell lines. Suppose the response of a
cell from the ith cell line is given by the random response vectorEi = (Ei1, Ei2, . . . , Eim).
This response vector can be quantitatively measured (for example, using invisible or visi-
ble fluorescence). The different components of Ei are assumed to be independent. This is
a reasonable assumption if the different components represent unrelated quantities. The al-
gorithm can be divided into two steps. The first step is the determination of the parameters
of Ei. The second step is the Bayesian estimation of pi.
2.2.1 Parameters of Ei
For the determination of parameters of Ei, we utilize the cell-by-cell observation. The
objective is to estimate the mean µij and standard deviation σij of Eij for 1 ≤ i ≤ n and
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1 ≤ j ≤ m. The cell-by-cell observations act as samples of the random vector Ei. The
sample mean and sample standard deviation represented as µˆij and σˆij act as estimates of
true mean and true standard deviation of Eij . Suppose there are p samples of each cell
line. The sample mean µˆij and sample standard deviation σˆij is given by:
µˆij =
1
n
p∑
k=1
eijk (2.1)
σˆij =
√∑p
k=1(eijk − µˆij)2
n− 1 (2.2)
where eijk are the samples of the random variable Eij .
2.2.2 Bayesian Estimate of pi
Obtaining the accurate estimate of pi, represented as pˆi, is the objective of the algorithm.
In order to achieve this, we proceed with estimating N = (N1, N2, . . . , Nn), where Ni is
the number of cells of cell line Ci. pˆi can be easily calculated as
pˆi =
N∑n
i=1Ni
(2.3)
The estimation of pi utilizes the observation from an ensemble experiment corresponding
to the cell-by-cell experiment. As an input, we have the overall response vector, Esum of
the heterogeneous cancer tissue. Esum is the result of a summation of the response vector
of each cell in the heterogeneous tissue. Each component of Esum, represented by Esumj ,
is given as:
Esumj = E1jN1sum + . . .+ EnjNnsum (2.4)
where,
EijNisum = Eij1 + . . .+ EijNi (2.5)
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Here, Eijk are independent identically distributed and have the same probability density
function as Eij for 1 ≤ k ≤ Ni.
Individually, EijNisum can be approximated as a Gaussian with mean Niµij and vari-
ance Niσ2ij by the Central Limit Theorem for sufficiently large Ni. For practical purposes,
the cell lines, which form a significant part of heterogeneous cancer tissue, satisfy the con-
dition of large Ni. Hence, the exact distribution of Eij becomes unimportant. This is a
very important implication as it gives the independence of choosing any feature as a part
of the observation vector irrespective of the probability distribution of the same. The only
condition is that the observation of the ensemble should be given by the summation of the
observation of individual cells in the tissue.
The likelihood of Esumj can be approximated by:
P (Esumj|N,µ, σ) ≈
1√
2pi(
∑n
i=1Niσ
2
ij)
e
− (Esumj−
∑n
i=1 µijNi)
2
2
∑n
i=1
Niσ
2
ij
(2.6)
As the components of Esum are independent, the likelihood of Esum is given by:
P (Esum|N,µ, σ) =
m∏
j=1
P (Esumj|N,µ, σ) (2.7)
This needs to be maximized over N in order to obtain a maximum likelihood estimate of
N . However, the complex expression makes it difficult to solve this problem analytically.
Another approach can be to evaluate the expression in (7) for different possible values of
N . However, the complexity of the algorithm is exponential and hence it is not feasible
when the number of different cell lines is large. Hence, we use a Bayesian approach to
estimate N .
The components of N have a uniform prior distribution. All the components of N
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are assumed to have a uniform prior from 0 to an arbitrarily large number, say M . The
posterior probability of Ni is given by:
P (Ni|Esum, N−i, µ, σ) =
P (Esum|N,µ, σ)P (Ni|N−i, µ, σ)∫
P (Esum|N ′i , N−i, µ, σ)P (N ′i |N−i, µ, σ)dN ′i
(2.8)
where N−i represents all the components of N excluding the ith component. As Ni is
independent of N−i, µ and σ, we have
P (Ni|N−i, µ, σ) = P (Ni) = 1/M (2.9)
P (Esum|N,µ, σ) can be calculated from 2.7. However, evaluating the denominator term of
2.8 is a complex problem. This makes the problem of calculating the posterior probability
of Ni from 2.8 infeasible. To address this issue, we resort to the Metropolis algorithm,
which is a Markov chain simulation to estimate the posterior distribution.
2.2.2.1 Metropolis Algorithm
The Metropolis algorithm comes in handy when it is difficult to exactly evaluate the
posterior probability. In such a scenario, if it is possible to sample directly from the pos-
terior distribution, we can generate independent identically distributed samples and use
them to approximate the posterior probability distribution. However, in our case, it is not
possible to sample directly from 2.8. To circumvent this issue, we use the full conditional
of Ni which is given by
P (Ni|Esum, N−i, µ, σ) ∝ P (Esum|N,µ, σ)P (Ni) (2.10)
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Suppose we have s samples of Ni from the posterior distribution in the set (Ni1, . . . , Nis).
We then consider adding the proposal value N∗i , which is in the vicinity of Nis. We follow
the following steps:
1. N∗i can be obtained by taking a sample from a symmetric proposal distribution. For eg,
N∗i can be sampled from uniform(Nis − δ,Nis + δ).
2. Compute the acceptance ratio r = P (N∗i |Esum, N−i, µ, σ)/P (Nis|Esum, N−i, µ, σ)
3. Assign Ni(s+1) = N∗i with probability min(r, 1) or Nis otherwise
Substituting P (Esum|N,µ, σ) and P (Ni) from 2.7 and 2.9 in 2.10 while performing step
2, we see that M cancels and hence the algorithm is independent of M . The Markov chain
formed by following the aforementioned steps has the same stationary distribution as the
posterior distribution of N . The Markov chain needs to run for a few initial iterations
before it reaches stationarity and only after that, the sampling has to be done. An impor-
tant consideration is the length of the neighborhood for the proposal distribution. If the
neighborhood is too small, the Markov chain will take too long to reach stationarity and
the samples will generate too many samples close to each other. Too large a neighborhood
would result in too many samples being rejected once the Markov chain has reached sta-
tionarity. Hence the value of neighborhood parameter needs to be tuned appropriately. We
draw samples from this Markov Chain after running it till it reaches stationarity. These
samples are used to estimate the posterior distribution of N . To do this, we use a non
parametric probability density function estimation, Kernel density estimation.
2.2.2.2 Kernel Density Estimation
Let (Ni1, Ni2, . . . , Nik) be the samples of the posterior distribution of Ni drawn from
the Metropolis algorithm. The Kernel Density Estimate of the posterior distribution is
given by:
fˆNi(ni|Esum, N−i, µ, σ) =
1
kh
k∑
j=1
K(
ni −Nij
h
) (2.11)
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Here, K is the Kernel function. Usually, K is a non-negative function with mean 0 and it
integrates to 1. In our case, we will consider K to be standard normal.
If K is smooth, the density estimate obtained is also smooth which is the advantage
offered by this density estimation method. An important consideration for the accuracy of
density estimation is the value of the bandwidth parameter, h. A low value of h results in
high variance in the estimation. A high value of h results in high bias in the estimation.
The optimal value of h which minimizes the squared error cost is given by:
hopt = Dk
−1/5 (2.12)
whereD = R(K)
1/5
(R(f ′′)σ4K)(1/5)
whereR(g) =
∫
g2(x)dx Since it involves f , where f is the true
posterior distribution, it is not possible to calculate the exact value of h. An approximation
for the optimal value of h can be obtained assuming f to be Gaussian. This bandwidth is
called the plug in bandwidth and is given by the expression
hˆplugin = 1.06sk
−1/5, s2 =
1
k − 1
k∑
j=1
(Nij − N¯i)2 (2.13)
Once the posterior density function estimation is done, we can evaluate the posterior mean,
the value of N which has maximum posterior probability, the confidence interval, etc. to
come to conclusions about the composition of the heterogeneous cancer tissue.
9
3. RESULTS
The performance of the algorithm is tested for simulated data and experimental data.
We use simulated data to study the performance of the algorithm as various parameters
change. The parameters taken into account are class of probability distribution of the
response vector, similarity of the expression profile, and standard deviation of the compo-
nents of the response vector. We study their impact on the confidence interval and accuracy
of the results.
3.1 Simulated Data
In order to demonstrate the performance of the proposed algorithm, we test its perfor-
mance on synthetic data. To do so, we first generate the samples for cell-by-cell analysis.
We consider a two cell type system. The number of cells of ith type with maximum poste-
rior probability is considered to be the value of Ni. Once Ni has been determined, we can
calculate pˆi using 2.3. The root square error, e, of the estimate of pi is used as the parameter
to evaluate the performance.
e =
√√√√ n∑
i=1
(pii − pˆi)2 (3.1)
We use the simulated data to perform a variety of analysis. We first evaluate the algorithm
in a scenario where the elements of the response vector are exponentially distributed. In or-
der to perform the analysis, we generate 2000 samples for cell-by-cell analysis to estimate
the mean and standard deviation of the individual components in the response vector of the
cell lines. The response vector has 2 components. In our analysis we set µ11 = µ22 = 100
and µ12 = µ21 = kµ11 where 0 < k < 1. Changing the value of k varies the similarity
between the response profile of the individual cell lines. k = 0 corresponds to a case when
the response profiles of the individual cell lines are the most dissimilar. k = 1 corresponds
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to the case when the response profile of both the cell lines are exactly the same and there-
fore it is not possible to differentiate between the cell lines. Since the inherent distribution
is exponential, we have σ11 = σ22 = 100 and σ12 = σ21 = kσ11. The simulation is
performed for 3 different values of k, k = 0, k = 0.3, k = 0.7. The idea is to show that
as the similarity between the expression profile of the different components decreases, the
confidence interval of the posterior probability distribution becomes narrower, that is, the
performance of the algorithm improves. We generate the ensemble observation data by
taking samples from the same µ and their summation acts as an input to the algorithm.
The samples are generated such that Cell Type 1 has 2000 cells and Cell Type 2 has 3000
cells in the heterogeneous mixture. This corresponds to pi = (0.4, 0.6). This is the case
that has been used in all the simulations with synthetic data. While running the Metropolis
Algorithm, we let the Markov chain run for 10000 iterations before sampling so that it
reaches stationarity. The neighborhood in the Metropolis Algorithm is tuned such that ap-
proximately one third of the proposed values are accepted. This procedure is followed for
both, the simulated data and the experimental data. The results in Figure 3.1 show that the
observation is on the expected lines as we can see the confidence interval getting narrower
as the values of k is increasing. The error e for all the cases remains below 0.0060.
Next, we do the same analysis for the scenario when the elements of the response vec-
tor are normally distributed. The value of µ remains the same as the exponential case and
so does the range of values of k. We assume constant coefficient of variation, which im-
plies that the variance of the normally distributed elements of response vector is a constant
multiple of its mean, that is, σ2ij = cµij . The analysis is done for c = 6 and we again
observe the effect of similarity in expression profiles for the two cell types on the confi-
dence interval. The results as shown in Figure 3.2 shows the confidence interval becoming
narrower as the value of k decreases. We also study the error performance as the value
of k increases. We observe that after a certain threshold close to 1, the error shoots up as
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Figure 3.1: Posterior Probability Distribution ofN for Exponentially Distributed Elements
of the Response Vector
Figure 3.2: Posterior Probability Distribution of N for Gaussian Distributed Elements of
the Response Vector
12
Figure 3.3: Error Performance for Increasing k
demonstrated in Figure 3.3.
We next analyze the impact of the standard deviation of the components of the response
vector on the performance of the algorithm. To perform this analysis, we set µ11 = µ22 =
100 and µ12 = µ21 = 0. To study the effect of the variance, we vary the value of c. For
the case when the variance is lower, we expect the confidence interval to be narrower. The
results, given in Figure 3.4, show that this is in fact the case upon running the algorithm
for c = 0.5, c = 2, c = 5 and c = 10. We also demonstrate the error performance with
increasing value of c, which is shown in Figure 3.5.
3.2 Experimental Data
The algorithm is tested for a heterogeneous mixture of three separate human cancer cell
lines, HCT116 (Colon Cancer), A2058(Melanoma) and SW480 (Colorectal carcinoma).
The response vector is composed of Red, Green and Blue fluorescence. There are three
13
Figure 3.4: Posterior Probability Distribution of N for Increasing Variance
Figure 3.5: Error Performance for Increasing c
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Experiment pi pˆi e
Untreated Mixture 1 [0.33 0.40 0.27] [0.40 0.48 0.12] 0.1838
Untreated Mixture 2 [0.37 0.19 0.44] [0.29 0.16 0.55] 0.1393
Lapatinib Mixture 1 [0.29 0.41 0.30] [0.24 0.40 0.36] 0.0787
Lapatinib Mixture 2 [0.35 0.16 0.49] [0.25 0.12 0.63] 0.1766
Temsirolimus Mixture 1 [0.31 0.42 0.28] [0.32 0.50 0.18] 0.1285
Temsirolimus Mixture 2 [0.41 0.16 0.43] [0.28 0.14 0.58] 0.1995
Table 3.1: Inherent and Estimated Values of pi
cases - the mixture is untreated, treated with Lapatinib and treated with Temsirolimus. For
each of the three cases, there are two different mixtures. Hence, overall there are six test
cases. In each case we know the true ratio pi of the cell lines in the mixture. We evaluate
performance by evaluating e as given by Table 3.1. The posterior probability distribution
for all the test cases are presented in Figures 3.6, 3.7, 3.8, 3.9, 3.10 and 3.11. The values
pi, pˆi and e are shown in the table below. The first, second and third components of pi
correspond to the ratio of HCT116, A2058 and SW480 respectively. As is clear from the
observation, in every case, the algorithm determines the concentration of the three cell
lines quite well.
3.3 Important Considerations
There are multiple factors crucial for the performance of the algorithm. Firstly, it
should be made sure that in the cell-by-cell analysis, enough samples are there to arrive
at an accurate estimate of the mean and variance. Secondly, the experimental setup has
to be standard as a variation of the setup from the one used for estimation of parameters
of response vectors can lead to a change in the parameters when the heterogeneous tissue
is being analyzed and will ultimately result in inaccurate results. This phenomena is ob-
served in the experimental results, which explains the accuracy of the algorithm being less
for experimental data compared to simulated data. Thirdly, the algorithm performs best
15
Figure 3.6: Posterior Probability Distribution of N for Untreated Mixture 1
Figure 3.7: Posterior Probability Distribution of N for Untreated Mixture 2
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Figure 3.8: Posterior Probability Distribution of N for Mixture 1 Treated with Lapatinib
Figure 3.9: Posterior Probability Distribution of N for Mixture 2 Treated with Lapatinib
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Figure 3.10: Posterior Probability Distribution of N for Mixture 1 Treated with 
Temsirolimus
Figure 3.11: Posterior Probability Distribution of N for Mixture 2 Treated with 
Temsirolimus
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when the number of cells of cell lines are large, especially for cell lines whose elements
of response vector have high standard deviation. This is because, even though the distri-
bution of the summation of the different components of response vector approximates to
a Gaussian distribution, the overall response can be far from the peak of the Gaussian if
there are not enough samples.
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4. SUMMARY AND CONCLUSIONS
In this work we address the challenge of determining the composition of any hetero-
geneous cancer tissue. It uses the advantage offered by the expensive cell-by-cell analysis
methods while actually utilizing the low cost ensemble methods. The algorithm takes the
characteristics of the response vector individual cell lines and the output of the ensem-
ble method as inputs. Based on these inputs, the algorithm uses a Bayesian approach to
estimate the number of cells of different cell lines that are present in the heterogeneous
mixture. In order to estimate the posterior probability, the algorithm uses the Metropolis
algorithm to gather samples from the posterior distribution and Kernel Density Estimation
to estimate the distribution from these samples.
20
REFERENCES
[1] N. A. Saunders, F. Simpson, E. W. Thompson, M. M. Hill, L. EndoMunoz, G. Leg-
gatt, R. F. Minchin, and A. Guminski, “Role of intratumoural heterogeneity in cancer
drug resistance: molecular and clinical perspectives,” EMBO Mol Med, vol. 4, no. 8,
pp. 675–684, 2012.
[2] P. C. Nowel, “The clonal evolution of tumor cell populations,” Science, vol. 194, no.
4260, pp. 23–28, 1976.
[3] A. K. Mohanty, A. Datta, and V. Venkatraj, “A model for cancer tissue heterogeneity,”
IEEE Transactions on Biomedical Engineering, vol. 61, no. 3, pp. 966–974, 1976.
[4] C. Sima, J. Hua, R. Lopes, A. Datta, and M. L. Bittner, “Detecting cell growth and
drug response in heterogeneous populations: A dynamic imaging approach,” in 2016
IEEE 16th International Conference on Bioinformatics and Bioengineering (BIBE),
pp. 121–128, Oct 2016.
21
